Sun Pharma to acquire Organon for $11.75 billion
pre-market1 source ↓written by the desknot a recommendation
- all-cash deal
- $11.75 billion
- priced
- $14 per share
- from its cash
- $2 billion to $2.5 billion
Sun Pharmaceutical Industries has signed a definitive agreement to acquire Organon & Company in a $11.75 billion all-cash deal, priced at $14 per share. The transaction, expected to close within six to nine months, will utilize $2 billion to $2.5 billion from its cash surplus along with bank financing. This acquisition marks a significant strategic move for Sun Pharma.
Not investment advice. For informational purposes only.